Teton Advisors Inc. Trims Stock Position in InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU)

Teton Advisors Inc. decreased its stake in InfuSystem Holdings, Inc. (NYSEAMERICAN:INFU) by 2.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 195,000 shares of the medical instruments supplier’s stock after selling 5,000 shares during the quarter. Teton Advisors Inc. owned approximately 0.92% of InfuSystem worth $2,055,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of INFU. WINTON GROUP Ltd acquired a new stake in InfuSystem during the third quarter valued at $101,000. Citigroup Inc. grew its position in shares of InfuSystem by 124.1% during the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock valued at $488,000 after acquiring an additional 28,038 shares during the period. First Eagle Investment Management LLC increased its stake in shares of InfuSystem by 29.6% in the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock valued at $4,515,000 after purchasing an additional 107,001 shares in the last quarter. Heartland Advisors Inc. raised its holdings in InfuSystem by 17.6% in the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock worth $4,820,000 after purchasing an additional 75,000 shares during the period. Finally, Punch & Associates Investment Management Inc. raised its holdings in InfuSystem by 3.2% in the 3rd quarter. Punch & Associates Investment Management Inc. now owns 939,918 shares of the medical instruments supplier’s stock worth $9,061,000 after purchasing an additional 28,807 shares during the period. 71.13% of the stock is owned by institutional investors and hedge funds.

InfuSystem Stock Performance

NYSEAMERICAN:INFU traded down $0.49 during trading hours on Monday, reaching $7.63. 23,945 shares of the company were exchanged, compared to its average volume of 43,762. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.54 and a current ratio of 1.95. The stock has a market capitalization of $162.21 million, a PE ratio of 254.42 and a beta of 1.24. InfuSystem Holdings, Inc. has a twelve month low of $7.57 and a twelve month high of $11.44.

Analyst Ratings Changes

Separately, StockNews.com cut InfuSystem from a “strong-buy” rating to a “buy” rating in a research report on Monday.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.